Experimental results demonstrate promising performance on accurate glioma delineation (Dice score, 0.897) and MGMT status prediction (accuracy, 0.827; recall, 0.852; precision, 0.821; and F1 score, 0.836) coming from the model trained with FLAIR images. This evidence concerns the gene MGMT and central nervous system cancer.